Browse 3 Therapeutics companies funded by Abstract. See funding amounts, founder contacts, and investment details.
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Locus Biosciences develops CRISPR-engineered precision antibacterial platform designed to revolutionize the treatment of bacterial disease.
Unnatural Products is a biotech company that focuses on unlocking macrocyclic peptides to create drug therapies.
View all companies funded by Abstract across every industry and funding stage.
View Full Abstract Portfolio